fianlimab,cemiplimab
sanofi,regeneron
['fianlimab', 'cemiplimab', 'melanoma']
dr. omid hamid of answering questions after presenting clinical trial data at #asco2023. "significant durable response with fianlimab (anti-lag-3) and cemiplimab (anti-pd-1) in advanced melanoma: post adjuvant pd-1 analysis." #melanoma #research 
The Melanoma Research Alliance works to accelerate the pace of scientific discovery & translation. 100% of your donation goes to world-class melanoma research.